LYMPHOCYTE ACTIVATION IN SUBACUTE SCLEROSING PANENCEPHALITIS VIRUS AND CYTOMEGALOVIRUS INFECTIONS : IN VITRO STIMULATION IN RESPONSE TO VIRAL-INFECTED CELL LINES by Thurman, G. B. et al.
LYMPHOCYTE  ACTIVATION IN  SUBACUTE SCLEROSING 
PANENCEPHALITIS  VIRUS  AND  CYTOMEGALOVIRUS 
INFECTIONS 
IN  VITRO STIMULATION  IN  RESPONSE TO  VIRAL-INFECTED CELL LINES* 
BY  G. B.  THURMAN,:~ A. AHMED,  D.  M.  STRONG,  R.  C.  KNUDSEN, 
W.  R.  GRACE, AND K.  W.  SELL 
(From the Experimental Immunology Division,  Clinical  Medical Sciences  Department, 
Naval  Medical  Research  Institute,  National  Naval  Medical  Center, 
Bethesda, Maryland 20014) 
(Received for publication 19 June 1973) 
The cell-mediated immune system plays an important part in combating certain 
viral infections (1, 2). The failure to respond to "slow" viruses can result in chronic 
infections that cause serious pathology or even death (3-5). 
Conflicting  results have been reported regarding the ability of cell-mediated immune 
systems to respond to viral infection. For instance, patients suffering from subacute 
sderosing panencephalitis (SSPE) 1 are known to produce high titers of antibody (es- 
pecially in the cerebrospinal fluid)  (6). These patients can also respond adequately to 
various antigens other than the measles virus that has been implicated in this neuro- 
logic disorder (7, 8). However, lymphocyte responses to measles antigen either in vitro 
or in vivo have often produced conflicting  results (9, 10). Lischner, Sharma, and Grover 
(10) have suggested that the difficulties  encountered might stem  from the impurity, 
variability, or instability of the antigens used by various investigators. They specu- 
lated that measles-induced cell-surface antigens may be a more useful antigenic source 
than viral antigens. 
Recent progress by  Horta-Barbosa and associates  (11,  12)  on the isolation and 
growth of virus from brain and lymph node tissue of patients with SSPE has made it 
possible to prepare purified SSPE virus and SSPE virus-infected culture cells. Using 
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these preparations,  it was possible to investigate the status of cell-mediated immunity 
of SSPE patients to the specific antigens of the causative virus. We have recently re- 
ported  (13)  the preliminary finding of responsiveness of SSPE patients' lymphocytes 
to purified  SSPE virus as measured  by the production  of macrophage migration in- 
hibition factor  (MIF)  and  to  SSPE virus-infected cells as measured  by lymphocyte 
transformation.  Interestingly,  while  MIF  production  could  be  stimulated  by  the 
measles  virus,  transformation  did  not  occur with  the  isolated virus but only when 
vitally infected cells were used. 
This  report  confirms  our initial findings  with  SSPE virus-infected  cells and 
extends  the  experiments  to  another  type  of  "slow virus"  infection  caused by 
cytomegalovirus  (CMV).  Uncontrolled  infection  by  CMV  occurs  not  infre- 
quently  in  patients  who  have  been  strongly  immunosuppressed  for  renal  or 
bone  marrow  transplantation  (14,  15).  The  lymphocytes  from  patients  in- 
fected with CMV responded in vitro by production of MIF  when  cultured  with 
purified CMV but were transformed only by CMV-infected WI-38 cell lines. 
Materials and Methods 
Lymphocyte Separation.--Venous,  heparinized human blood was allowed to sediment 2-3 h. 
The leukocyte-rich plasma was removed by expulsion through the bent needle of the syringe 
and centrifuged 10 min at 200 g to sediment the leukocytes. The platelet-rich plasma was re- 
moved and hard spun (2,000 g, 20 rain)  to remove the platelets before it was used to supple- 
ment the culture media. The leukocytes were resuspended in culture media supplemented with 
antibiotics  (penicillin,  100 U/ml; streptomycin,  100/zg/ml)  and fresh L-glutamine (2 mM). 
This cell suspension was carefully layered on top of an equal volume of fresh filter-sterilized 
(0.22/zm Millipore [Millipore  Corp., Bedford, Mass.])  Ficoll-H:~l?aque gradient (sp gr 1.078) 
made by mixing four parts of an 8%  (wt/vol) Ficoll (Sigma Chemical Co., St. Louis, Mo.) 
solution with one part of 50% Hypaque  (Winthrop Laboratories, New York). The gradient 
and cell suspension were centrifuged for 40 min at ambient temperature providing 500 g at the 
interface. The band  of cells at the media-gradient interface was carefully aspirated  with a 
pipette and  then washed  once with media. This routinely gave 98-99%  lymphocytes with 
about a 60070 recovery. 
Virus-Infected  Cultured Cell Lines.--The  SSPE virus-infected HeLa cells and  uninfected 
HeLa cells were provided courtesy of Doctors Horta-Barbosa and Dietzman (National Insti- 
tute of Mental Health, National Institutes of Health, Bethesda, Md.). 
The Wistar-38 (WI-38), 40th passage, cells were obtained from Mr. Richard Grey (Depart- 
ment of Microbiology, Naval Medical Research Institute, Bethesda, Md.) and were grown in 
minimal essential media (MEM) supplemented with 10% fetal calf serum, 100 U of penicillin/ 
ml, 100 #g streptomycin/ml, 2 mM L-glutamine, 1 mM sodium pyruvate, and 1% nonessential 
amino acids (100 times solution). All were obtained from Grand Island Biological Co.  (New 
York).  Cultures were incubated  at  37°C  in a  humidified atmosphere  containing  5%  CO2. 
Confluent monolayers were infected with cytomegalovirus strain AD169 supplied courtesy of 
Dr.  Nicholas  Dunnick  (Division of  Biological  Standards,  National  Institutes  of  Health, 
Bethesda, Md.).  Infected cultures were maintained by transferring media from infected cul- 
tures  to uninfected cultures.  Cytomegalovirus-infected cells used  in these experiments had 
shown cytopathogenic effects for approximately 10 days. Infected and noninfected cells were 
harvested by trypsinization of monolayers. Cells were then washed twice with ME.:V[ and re- 
suspended in MEM with supplements. 
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thymidine in each experiment. Blocking was accomplished by incubation with 25/zg of mito- 
mycin C (Calbiochem, San Diego, Calif.) per ml at 37°C for 30 min. Blocked cells were washed 
twice in RPMI 1540 before use in cultures with lymphocytes. 
Mixed Lymphocyte-Infected Cell Culture (MLICC): Culture Preparation and Conditions.- 
Cell concentration of lymphocytes and cultured cells was determined in an Autocytometer II 
(Fisher Scientific Co., Pittsburgh, Pa.). Lymphocyte concentrations were adjusted to provide 
200,000 lymphocytes per 0.10 ml, and cultured HeLa or WI-38 cells were diluted to give either 
10,000 or 25,000 cells per 0.05 ml. The plasma concentration in RPMI 1540 was adjusted such 
that 0.05 ml of the dilution would give a final concentration of 10% in the 0.20 ml cultures. 
Only results with measles or CMV seronegative plasma are reported here. 
Triplicate  cultures  were  prepared  in  Microtest  II  microtiter  plates  (Falcon  Plastics, 
Division of BioQuest, Oxnard, Calif.). Rapid dispensing of lymphocytes, cultured cells,  and 
culture additives was accomplished with Hamilton repeating dispensers (Hamilton Co., Reno, 
Nev.). Cultures were incubated 72 h at 37°C in a 5% CO2 humidified atmosphere. 18 h before 
harvesting  0.02  ml  of RPMI  1640 containing  1 /zCi of  [methyl-~H]thymidine  (sp  act  1.9 
Ci/mM,  Schwarz/Mann  Div., Becton, Dickinson, and  Co., Orangeburg,  N.Y.)  was added. 
Harvesting was  accomplished using a  Multiple Automated  Sample Harvester  (MASH)  as 
previously  described  (16),  and  the  tritiated  thymidine  incorporation  was  determined  by 
scintillation spectrophotometry.  Data from the scintillation counter were recorded on paper 
tape and analyzed using a  Wang 700C  Advanced Programming Calculator  (Wang Labora- 
tories,  Tewksbury,  Mass.). 
RESULTS 
SSPE  Virus-Infected Patients.--Purified peripheral  blood lymphocytes from 
a  patient  (R.S.)  with  SSPE  showed  a  significant  response  to  SSPE  virus-in- 
fected HeLa cells (Table I). R.S.'s lymphocytes cultured with noninfected HeLa 
cells  gave  354  (-4-20)  cpm.  When  cultured  with  SSPE  virus-infected  cells 
TABLE I 
In  Vitro  Transformation  of Lymphocytes from Patients  with SSPE by SSPE  Virus-Infected 
HeLa Cells 
Source of lymphocytes* 
Uptake of [aH]thymidine 
0.1% PHA-P  Nonlnfected:~  SSPE-infected§  HeLa 
HeLa cells  cells 
cpm 4- SE 
None  --  227  (4-4)  546  (4-  34) 
Seronegative eontrolll  50,976  (4-5,127)  397  (-4-48)  444  (4-  19) 
Seropositivecontrol¶  42,975  (4-3,723)  287  (4-38)  174  (4-  19) 
SSPEno.  1"*  43,388  (4-4,481)  354  (4-20)  4,656  (4-1,197) 
SSPEno. 2~  65,801  (4-2,032)  599  (4-66)  6,651  (4-  293) 
* 200,000 lymphocytes per 0.2 ml culture. 
~t 10,000 HeLa cells per culture mitomycin C treated. 
§ 10,000 HeLa cells infected with SSPE virus, mitomycin C treated. 
II Seronegative control (A.A.)  titer  < 1:10 (CF). 
¶  Seropositive control (S.P.)  titer 1 : 128  (CF). 
** Patient (R.S.) with SSPE. 
:~$ Patient (O.H.) with SSPE. 842  LYMPHOCYTE  STIMULATION BY  VIRAL-INFECTED  CELLS 
(MLICC), they produced 4,656 (4-1,197) cpm, which gives a stimulation index 
of 13.9. 
In the MIF results on these same individuals (17), the seropositive control as 
well as the SSPE patient produced MIF when exposed to the purified SSPE 
virus.  However, Table I  indicates  that  in  the  MLICC,  seropositive control 
lymphocytes did not show a  blastogenic response to the SSPE virus-infected 
HeLa cells,  whereas  lymphocytes from the  SSPE patients  did.  None of the 
lymphocytes responded to the noninfected HeLa cells,  and the blastogenic re- 
sponses to 0.1% phytohemagglutinin P  (PHA-P) of all three lymphocyte types 
were within normal range. 
The lymphocyte response reported in Table I  was at 72 h  of incubation. A 
similar set of cultures incubated 120 h showed a decrease in response compared 
with the 72-h cultures. All further cultures were therefore harvested at 72 h. 
The results were confirmed by a second experiment with another SSPE pa- 
tient  (O.H.).  Lymphocytes from O.H.  cultured with  noninfected HeLa cells 
gave 599  (4-66)  cpm.  When  cultured  with  SSPE virus-infected HeLa cells, 
they responded with 7,571 (4-291) cpm, giving a stimulation index of 12.6. No 
response to noninfected HeLa cells was seen, and the mitogenic responses were 
within normal range. 
Cytomegalovirus (CMV)-Infected Patients.-To  test if this assay system was 
effective in determining the reactivity of lymphocytes from other types of viral- 
infected patients, the response of lymphocytes from CMV-infected patients in 
the MLICC was measured using CMV-infected WI-38 cells.  The results indi- 
cate specific responses similar to those seen in the SSPE cases  (Table II). 
Peripheral  blood  lymphocytes from  CMV-infected  patients  responded  in 
vitro to CMV-infected WI-38 cells.  The response was partially masked if the 
WI-38  cells were  not  pretreated  with  mitomycin  C.  Lymphocytes from  the 
CMV-infected patient (D.R.) when cultured with noninfected WI-38 cells gave 
4,560 (4-394) cpm, whereas when cultured with CMV-infected WI-38 cells, they 
gave 15,991  (4-1,506)  cpm.  This gives a  stimulation index of 3.5, due to the 
high  tritiated thymidine incorporation of the unblocked WI-38 cells.  Neither 
the seronegative nor seropositive control lymphocytes responded to the CMV- 
infected WI-38  cells.  Experiments with  lymphocytes from another CMV-in- 
fected patient  (C.W.) using mitomycin C-blocked CMV-infected WI-38 cells 
were confirmatory. C.W.'s lymphocytes with noninfected WI-38 cells gave 418 
(4-29) cpm, whereas with the infected WI-38 cells they gave 5,356 (4-314) cpm. 
The resulting stimulation index of 12.8 is in the range of the stimulation indices 
observed in the SSPE cases and when compared with the response to unblocked 
WI-38 cells indicates the importance of mitomycin C  treatment of the stimu- 
lating cells. 
DISCUSSION 
The most significant finding to emerge from these experiments is that lym- 
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TABLE II 
In  Vitro  Transformation  of Lymphocytes  from Patients with Cytomegalovirus Infections  Using 
CMV-Infected WI-38 Cells 
Source of lymphocytes* 
Uptake of [3H]thymidine 
0.1% PHA-P  Noninfected  WI-38  CMV-infected  WI-38 
cells~t  ceils§ 
ctnn .4- SE 
None  --  356  (4-  39)  538  (-4-  73) 
Seronegativecontrolll  65,749  (4-4,134)  487  (4-38)  456  (4-  11) 
Seropositivecontrol¶  53,611  (4-3,120)  339  (4-  27)  552  (4-  49) 
CMV patient no. 1"*  32,774  (4-2,027)  4,560  (-4-394):I~  15,991 (4-1,506) 
CMV patient no. 2§§  39,649  (4-1,986)  418  (4-  29)  5,356  (4-  314) 
* 200,000 lymphocytes per 0.2 ml culture. 
:~ 10,000 WI-38 cells per culture mitomycin C treated except for data on CMV patient no. 
1. 
§ 10,000 WI-38 cells infected with CMV. The infected WI-38 cells were treated with mito- 
mycin C except for data on CMV patient no. 1. 
[] Seronegative control (A.A.) titer  <1:4 (CF). 
¶ Seropositive control  (M.L.) titer  1:64 (CF). 
** Patient (D.R.) with CMV infection. 
~;~ Response to nonmitomycin C-treated  WI-38 cells. 
§§ Patient (C.W.) with CMV infection. 
culture  to tissue culture cells infected with their specific type of virus.  Such a 
response indicates that the etiology of the diseases is not an inability to respond 
to the virus in vivo through a defect in cell-mediated immunity (9, 10). Indica- 
tions are that the lack of response is due to a factor present in the plasma and 
cerebrospinal fluids of the patients  that blocks the response of immunocompe- 
tent lymphocytes (13,  17). 
Rosenberg, Farber, and Notkins (18) report 30-fold stimulation of sensitized, 
rabbit splenic lymphocytes in vitro with ultraviolet (UV) light-inactivated her- 
pes  simplex  virus  and  vaccinia virus.  However,  extensive  experiments  (4,000 
cultures)  in  our  laboratories  using  active  and  UV-inactivated  measles  virus, 
SSPE virus, and CMV strain AD169 cultured in vitro with lymphocytes from 
SSPE  or CMV-infected  patients  and  controls  failed  to show  any meaningful 
stimulation. 
Our studies  using the macrophage migration  inhibition  factor (MIF)  assay 
first indicated  the reactivity of the patient's lymphocytes and the presence of 
a blocking factor in the plasma and cerebrospinal fluid of the virus-infected pa- 
tients  (13,  17). However, in the MIF assay, measles seropositive controls also 
showed MIF production in response to the SSPE virus, and this response could 
be eliminated  by the  blocking factor.  In the  transformation  studies  reported 
here,  there was no response of the measles seropositive  controls to  the  SSPE 
virus-infected HeLa cells.  The exact meaning of this  observation is presently 
unclear.  It may be that different antigens are involved in stimulating  the dif- 844  LYMPHOCYTE  STIMULATION BY  VIRAL-INFECTED  CELLS 
ferent responses measured, i.e., viral envelope antigens stimulating MIF pro- 
duction, and viral-induced cell surface antigens causing the lymphocyte blasto- 
genesis. The lack of blastogenic response by the positive control to the SSPE 
virus-infected cells would seem to indicate nonsensitization to the new cell sur- 
face antigens induced by the SSPE viral genome. Studies are needed to investi- 
gate the responsiveness of controls and SSPE patients to measles virus-infected 
cell lines and to determine the extent of cross-reactivity between the cell surface 
antigens from measles and SSPE virus-infected cell lines. The cultured cell lines 
may only serve to present the viral antigens in a  stimulatory form to the re- 
sponsive lymphocytes, but this does not account for the discrepancy between 
the positive response of the measles seropositive control in the MIF assay and 
the negative response in the MLICC assay. The possibility that the SSPE virus 
may be an altered measles virus or a mutant of measles virus has been suggested 
(5). In the MIF assay, one is measuring the release of preformed cellular prod- 
ucts in response to specific antigen, whereas in blastogenesis, there is an active 
process whereby presensitized cells undergo DNA synthesis in response to spe- 
cific antigens.  MIF is measured 24 h  after the contact of viral antigen with 
sensitized cells, whereas in blastogenesis the response is measured 72 h after the 
contact of viral antigen with sensitized cells. It is possible that viruses are neu- 
tralized by in vitro interferon production by sensitized cells and therefore not 
available for stimulation of the cells, whereas using virus-infected cells, the anti- 
gens  are  so provided that cells do not respond  by producing interferon and 
therefore a good source of antigen for specific stimulation. 
The implications of these findings in the clinical management of patients with 
slow virus diseases is significant. The fact that the patients' lymphocytes have 
the capacity to respond to the viral-infected cells argues against  the possible 
therapeutic use of transfer factor or immune lymphocyte transfusions. The role 
of patients' plasma and spinal fluid in the MLICC assay is currently under in- 
vestigation. The possibility of such assays utilizing viral-infected cell lines could 
prove to be a very important tool for assessing the cellular immune function of 
patients with chronic slow virus diseases. 
SUMMARY 
Efforts to stimulate lymphocytes from measles seropositive and two patients 
with  subacute  sclerosing  panencephalitis  (SSPE)  with  either  commercially 
available measles virus or virus isolated from a known case of SSPE failed to 
show any significant data using a microculture assay. Similar results were ob- 
tained  using  lymphocytes  from  two  patients  with  active  cytomegalovirus 
(CMV) infections and CMV seropositive individuals using CMV suspensions. 
On the other hand, lymphocytes from the patients with subacute sclerosing 
panencephalitis  exhibited in vitro blastogenesis in culture with  SSPE virus- 
infected HeLa cells.  Similarly, lymphocytes from the CMV-infected patients 
demonstrated blastogenesis when cocultivated with CMV-infected WI-38 cells. THURMAN, AHMED, STRONG, KNUDSEN, GRACE, AND  SELL  845 
This affords a new method for determining the cell-mediated immune capacity 
of patients with "slow" virus diseases. 
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